0001179110-19-007208.txt : 20190605 0001179110-19-007208.hdr.sgml : 20190605 20190605164919 ACCESSION NUMBER: 0001179110-19-007208 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190528 FILED AS OF DATE: 20190605 DATE AS OF CHANGE: 20190605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wilhoit Scott L. CENTRAL INDEX KEY: 0001778589 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37569 FILM NUMBER: 19880357 MAIL ADDRESS: STREET 1: 900 NORTHBROOK DRIVE STREET 2: SUITE 200 CITY: TREVOSE STATE: PA ZIP: 19053 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Strongbridge Biopharma plc CENTRAL INDEX KEY: 0001634432 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981130690 STATE OF INCORPORATION: L2 BUSINESS ADDRESS: STREET 1: 900 NORTHBROOK DRIVE, SUITE 200 CITY: TREVOSE STATE: PA ZIP: 19053 BUSINESS PHONE: (610) 254-9200 MAIL ADDRESS: STREET 1: 900 NORTHBROOK DRIVE, SUITE 200 CITY: TREVOSE STATE: PA ZIP: 19053 FORMER COMPANY: FORMER CONFORMED NAME: Cortendo AB DATE OF NAME CHANGE: 20150219 4 1 edgar.xml FORM 4 - X0306 4 2019-05-28 0 0001634432 Strongbridge Biopharma plc SBBP 0001778589 Wilhoit Scott L. 900 NORTHBROOK DRIVE SUITE 200 TREVOSE PA 19053 0 1 0 0 Chief Commercial Officer Employee Stock Option (right to buy) 2.84 2019-05-28 4 A 0 50000 0 A 2029-05-28 Common Stock 50000 50000 D This option becomes exercisable as to 12,500 shares on May 28, 2020, with the remaining 37,500 shares becoming exercisable in twelve equal quarterly installments thereafter, provided the Reporting Person is employed by the Issuer on each vesting date. /s/ Stephen J. Long, as attorney-in-fact 2019-06-05